Gambaro M G, Genoni P, Berra D
Unità Operativa di Pneumologia, U.S.S.L. n. 8, Busto Arsizio.
Minerva Med. 1988 Jul;79(7):563-8.
After considering the bacterial flora which is most common in relapses in patients with bronchitis, 40 patients with chronic bronchitis have been treated with tetroxoprim a recently synthetized benzyl pyrimidine associated with sulfadiazine. One 350 mg tablet was administered every 12 hours for different periods, from 7 to 14 days. This study has shown how tetroxoprim has a wide antibacterial range, how it is well tolerated and extremely powerful in treating relapses of chronic infections in bronchi.
在考虑了支气管炎患者复发时最常见的细菌菌群后，40例慢性支气管炎患者接受了四氧普明治疗，四氧普明是一种最近合成的与磺胺嘧啶相关的苄基嘧啶。每12小时服用1片350毫克的药片，服用不同疗程，从7天到14天不等。这项研究表明，四氧普明具有广泛的抗菌谱，耐受性良好，在治疗支气管慢性感染复发方面极其有效。
